IgG endopeptidase in highly sensitized patients undergoing transplantation

<strong>BACKGROUND</strong> Donor-specific antibodies create an immunologic barrier to transplantation. Current therapies to modify donor-specific antibodies are limited and ineffective in the most highly HLA-sensitized patients. The IgG-degrading enzyme derived from Streptococcus pyogen...

Full description

Bibliographic Details
Main Authors:	Jordan, S, Lorant, T, Choi, J, Kjellman, C, Winstedt, L, Bengtsson, M, Zhang, X, Eich, T, Toyoda, M, Eriksson, B, Ge, S, Peng, A, Järnum, S, Wood, K, Lundgren, T, Wennberg, L, Bäckman, L, Larsson, E, Villicana, R, Kahwaji, J, Louie, S, Kang, A, Haas, M, Nast, C, Vo, A, Tufveson, G
Format:	Journal article
Language:	English
Published:	Massachusetts Medical Society 2017

IgG endopeptidase in highly sensitized patients undergoing transplantation

Similar Items